Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Merck (MRK) has a market cap of $243.45 billion USD. According to our data, Merck is ranked No.44 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $243.45 B |
-3.26%
|
| Dec 31, 2024 | $251.65 B |
-6.26%
|
| Dec 29, 2023 | $268.45 B |
1.01%
|
| Dec 30, 2022 | $265.77 B |
49.42%
|
| Dec 31, 2021 | $177.87 B |
1.75%
|
| Dec 31, 2020 | $174.80 B |
-7.20%
|
| Dec 31, 2019 | $188.37 B |
22.27%
|
| Dec 31, 2018 | $154.06 B |
39.95%
|
| Dec 29, 2017 | $110.08 B |
-1.49%
|
| Dec 30, 2016 | $111.74 B |
15.05%
|
| Dec 31, 2015 | $97.12 B |
-3.89%
|
| Dec 31, 2014 | $101.05 B |
16.93%
|
| Dec 31, 2013 | $86.42 B |
26.83%
|
| Dec 31, 2012 | $68.14 B |
13.14%
|
| Dec 30, 2011 | $60.23 B |
9.56%
|
| Dec 31, 2010 | $54.97 B |
2.91%
|
| Dec 31, 2009 | $53.41 B |
26.70%
|
| Dec 31, 2008 | $42.16 B |
-45.33%
|
| Dec 31, 2007 | $77.12 B |
37.35%
|
| Dec 29, 2006 | $56.15 B |
42.68%
|
| Dec 30, 2005 | $39.35 B |
4.04%
|
| Dec 31, 2004 | $37.82 B |
-27.77%
|
| Dec 31, 2003 | $52.36 B |
-11.20%
|
| Dec 31, 2002 | $58.96 B |
-1.21%
|
| Dec 31, 2001 | $59.69 B |
-35.96%
|
| Dec 29, 2000 | $93.20 B |
41.76%
|
| Dec 31, 1999 | $65.75 B |
-7.49%
|
| Dec 31, 1998 | $71.07 B |
41.30%
|
| Dec 31, 1997 | $50.29 B |
35.65%
|
| Dec 31, 1996 | $37.08 B |
23.94%
|
| Dec 29, 1995 | $29.92 B |
76.61%
|
| Dec 30, 1994 | $16.94 B |
14.85%
|
| Dec 31, 1993 | $14.75 B |
-18.33%
|
| Dec 31, 1992 | $18.06 B |
-20.31%
|
| Dec 31, 1991 | $22.66 B |
88.89%
|
| Dec 31, 1990 | $12.00 B |
18.94%
|
| Dec 29, 1989 | $10.09 B |
37.47%
|
| Dec 30, 1988 | $7.34 B |
11.95%
|
| Dec 31, 1987 | $6.56 B |
29.98%
|
| Dec 31, 1986 | $5.04 B |
84.58%
|
| Dec 31, 1985 | $2.73 B |
50.10%
|
| Dec 31, 1984 | $1.82 B |
7.68%
|
| Dec 30, 1983 | $1.69 B |
10.19%
|
| Dec 31, 1982 | $1.53 B |
3.61%
|
| Dec 31, 1981 | $1.48 B |
3.07%
|
| Dec 31, 1980 | $1.44 B |
21.27%
|
| Dec 31, 1979 | $1.18 B |
10.05%
|
| Dec 29, 1978 | $1.08 B |
25.58%
|
| Dec 30, 1977 | $0.86 B |
-16.23%
|
| Dec 31, 1976 | $1.02 B |
0.45%
|
| Dec 31, 1975 | $1.02 B |
6.26%
|
| Dec 31, 1974 | $0.96 B |
-16.59%
|
| Dec 31, 1973 | $1.15 B |
-8.09%
|
| Dec 29, 1972 | $1.25 B |
45.39%
|
| Dec 31, 1971 | $0.86 B |
27.85%
|
| Dec 31, 1970 | $0.67 B |
-10.76%
|
| Dec 31, 1969 | $0.75 B |
28.29%
|
| Dec 31, 1968 | $0.59 B |
8.98%
|
| Dec 29, 1967 | $0.54 B |
12.11%
|
| Dec 30, 1966 | $0.48 B |
11.03%
|
| Dec 31, 1965 | $0.43 B |
45.04%
|
| Dec 31, 1964 | $0.30 B |
39.31%
|
| Dec 31, 1963 | $0.21 B |
43.39%
|
| Dec 31, 1962 | $0.15 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Pfizer
PFE
|
$149.69 B |
-1.275 B
|
USA
|
 Johnson & Johnson
JNJ
|
$346.00 B |
-10.690 B
|
USA
|
 Bristol-Myers Squibb
BMY
|
$114.88 B |
-0.811 B
|
USA
|
 Eli Lilly
LLY
|
$670.90 B |
3.292 B
|
USA
|
 AbbVie
ABBV
|
$299.69 B |
-5.337 B
|
USA
|
 Amgen
AMGN
|
$147.39 B |
-0.333 B
|
USA
|
 Gilead Sciences
GILD
|
$115.25 B |
-0.604 B
|
USA
|
 AstraZeneca
AZN
|
$211.39 B |
0.636 B
|
UK
|
 GlaxoSmithKline
GSK
|
$68.73 B |
-0.194 B
|
UK
|
 Sanofi
SNY
|
$129.28 B |
-0.313 B
|
France
|
 Novartis
NVS
|
$197.89 B |
-1.499 B
|
Switzerland
|
 Takeda Pharmaceutical
TAK
|
$41.29 B |
-0.238 B
|
Japan
|
 Biogen
BIIB
|
$20.75 B |
0.203 B
|
USA
|
| Market Cap | = | MRK Stock Price | * | MRK Shares Outstanding |
| = | $96.24 | * | 2.53 B | |
| = | $243.45 B |